178 related articles for article (PubMed ID: 21443283)
1. Ganciclovir ophthalmic gel 0.15%: in acute herpetic keratitis (dendritic ulcers).
Croxtall JD
Drugs; 2011 Mar; 71(5):603-10. PubMed ID: 21443283
[TBL] [Abstract][Full Text] [Related]
2. Ganciclovir ophthalmic gel (Virgan; 0.15%) in the treatment of herpes simplex keratitis.
Colin J; Hoh HB; Easty DL; Herbort CP; Resnikoff S; Rigal D; Romdane K
Cornea; 1997 Jul; 16(4):393-9. PubMed ID: 9220235
[TBL] [Abstract][Full Text] [Related]
3. Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis.
Kaufman HE; Haw WH
Curr Eye Res; 2012 Jul; 37(7):654-60. PubMed ID: 22607463
[TBL] [Abstract][Full Text] [Related]
4. Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study.
Hoh HB; Hurley C; Claoue C; Viswalingham M; Easty DL; Goldschmidt P; Collum LM
Br J Ophthalmol; 1996 Feb; 80(2):140-3. PubMed ID: 8814744
[TBL] [Abstract][Full Text] [Related]
5. The treatment of herpes simplex virus epithelial keratitis.
Wilhelmus KR
Trans Am Ophthalmol Soc; 2000; 98():505-32. PubMed ID: 11190039
[TBL] [Abstract][Full Text] [Related]
6. Ganciclovir ophthalmic gel in herpes simplex virus rabbit keratitis: intraocular penetration and efficacy.
Castela N; Vermerie N; Chast F; Sauvageon-Martre H; Denis J; Godard V; Goldschmidt P; Pouliquen Y
J Ocul Pharmacol; 1994; 10(2):439-51. PubMed ID: 8083563
[TBL] [Abstract][Full Text] [Related]
7. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.
Romanowski EG; Bartels SP; Gordon YJ
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596
[TBL] [Abstract][Full Text] [Related]
8. Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications.
Chou TY; Hong BY
Ther Clin Risk Manag; 2014; 10():665-81. PubMed ID: 25187721
[TBL] [Abstract][Full Text] [Related]
9. Topical ganciclovir in the treatment of acute herpetic keratitis.
Tabbara KF; Al Balushi N
Clin Ophthalmol; 2010 Aug; 4():905-12. PubMed ID: 20823931
[TBL] [Abstract][Full Text] [Related]
10. Treatment of pseudodendrites in herpes zoster ophthalmicus with topical ganciclovir 0.15% gel.
Aggarwal S; Cavalcanti BM; Pavan-Langston D
Cornea; 2014 Feb; 33(2):109-13. PubMed ID: 24322809
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of 0.15% ganciclovir in situ ophthalmic gel for herpes simplex keratitis - a multicenter, randomized, investigator-masked, parallel group study in Chinese patients.
Lin T; Gong L; Sun XH; Zhao NQ; Chen W; Yuan HP; Shao Y; Gao MH; Tang H
Drug Des Devel Ther; 2013; 7():361-8. PubMed ID: 23761964
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic interventions for herpes simplex virus epithelial keratitis.
Wilhelmus KR
Cochrane Database Syst Rev; 2008 Jan; (1):CD002898. PubMed ID: 18254009
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of acyclovir-resistant herpetic keratitis and experimental studies of isolates.
Yao YF; Inoue Y; Kase T; Uchihori Y; Mori Y; Ohashi Y
Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234 Suppl 1():S126-32. PubMed ID: 8871163
[TBL] [Abstract][Full Text] [Related]
14. HPMPC, a broad-spectrum topical antiviral agent, inhibits herpes simplex virus type 1 replication and promotes healing of dendritic keratitis in the New Zealand rabbit ocular model.
Gordon YJ; Romanowski EG; Araullo-Cruz T
Cornea; 1994 Nov; 13(6):516-20. PubMed ID: 7842711
[TBL] [Abstract][Full Text] [Related]
15. Effect of oral valaciclovir on herpetic keratitis.
Higaki S; Itahashi M; Deai T; Fukuda M; Shimomura Y
Cornea; 2006 Dec; 25(10 Suppl 1):S64-7. PubMed ID: 17001196
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic interventions for herpes simplex virus epithelial keratitis.
Wilhelmus KR
Cochrane Database Syst Rev; 2007 Jan; (1):CD002898. PubMed ID: 17253484
[TBL] [Abstract][Full Text] [Related]
17. Development of Herpes Simplex Virus Infectious Epithelial Keratitis During Oral Acyclovir Therapy and Response to Topical Antivirals.
Carter SB; Cohen EJ
Cornea; 2016 May; 35(5):692-5. PubMed ID: 26989961
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of acyclovir in the treatment of ulcerative herpetic keratitis.
Shiota H
Am J Med; 1982 Jul; 73(1A):307-10. PubMed ID: 7048917
[TBL] [Abstract][Full Text] [Related]
19. Acute Herpetic Keratitis: What is the Role for Ganciclovir Ophthalmic Gel?
Sahin A; Hamrah P
Ophthalmol Eye Dis; 2012; 4():23-34. PubMed ID: 23650455
[TBL] [Abstract][Full Text] [Related]
20. A systematic review and meta-analysis to compare the efficacy of acyclovir 3% ophthalmic ointment to idoxuridine in curing herpetic keratitis by Day 7 of treatment.
Balderson DE; Cai G; Fries MA; Kleinman DM; McLaughlin MM; Trivedi TM; Wurzelmann JI; Young SB
BMC Ophthalmol; 2015 Apr; 15():42. PubMed ID: 25928630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
